Bardin Hill Management Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-141,207
Closed -$20.6M 111
2022
Q2
$20.6M Buy
+141,207
New +$20.6M 5.36% 4